The Galaxy Team at Penn State and Emory (http://galaxyproject.org) is looking for ambitious individuals to fill multiple postdoctoral and software engineering positions. Galaxy is used by thousands of researchers worldwide on a daily basis and multiple institutions run local instances of our software. Because Galaxy is primarily a tool and data integration framework, it is ideally suited by analysis of next-generation sequencing (NGS) data. The advertised jobs will focus extensively on design of best practice workflows for biological applications of NGS data including re-sequencing, de novo assembly, metagenomics, transcriptome analysis and epigenetics. Our current level of funding provides good job security and our project is well known, enabling excellent possibilities for subsequent career choices. To apply, e-mail cover letter, resume that includes highlights of your biological or software development experience, and contact information for three references to ([email protected]). Galaxy is an open source project committed to the openness of scientific enterprise. It is free for all.
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...10-30-2026, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM